Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Gilead/AbbVie Week 16/6 Script Numbers Reported By IMS Health

|Includes: ABBV, Gilead Sciences, Inc. (GILD)

Gilead (NASDAQ:GILD) week 16 script numbers.

Script Numbers Current Week Previous Week % Change
Harvoni TRx 7811 7049

10.8

Harvoni NRx 3781 3627 4.2
Harvoni/Sovaldi TRx 9820 8962 9.6
Harvoni/Sovaldi NRx

5220

4450 17.3

AbbVie (NYSE:ABBV) week 6 script numbers.

Script Numbers Current Week Previous Week % Change
Viekira Pak TRx 214 134 59.7
Viekira Pak NRx unk 120

unk

Prescriptions for Gilead's Harvoni continue to increase. Citigroup's Yaron Werber and Kumaraguru Raja explain:

Harvoni weekly TRx increased 10.8% and NRx increased 4.2%. TRx scripts are 7,811 up from 7,049 and NRx scripts are 3,781 up from 3,627 last week. Gilead Q1 HCV sales are tracking at $2.3B vs. Citi's estimate of $2.15B. We're predicting a 46% gross to net discount and 5% growth in Harvoni TRx every week and flat Sovaldi TRx for rest of the quarter.

Disclosure: The author is long GILD.